7/10/2013China Offers New Possibilities For Drug License Transfers

7/10/2013SinoPharm CNBG Confirms Plan for Hong Kong IPO within 2013

7/9/2013Updated - USFDA Found China Data Irregularities for Key Study of Pfize...

7/9/2013CDE Issues Implementation Plan for Streamlining Drug Clinical Trial Da...

7/8/2013Soligenix and SciClone Enter Personalized Medicine Collaboration

7/8/2013More GSK Bribery Allegations Emerge

7/8/2013China Ups Pressure on Drug Costs As It Pushes Forward Designated Produ...

7/7/2013China a Research Superpower But We Could Be Left in Dark

7/5/2013Chinese Pharma Growth Slows, But with Unchanged Long Term Positive Vie...

7/5/2013WiCON Officially Publishes Its China Pharmaceutical Guide 2013 (8th Ed...

7/5/2013Update on China's Probe of GSK

7/5/2013Nolato Expands Injection Moulding Production Capacity in China

7/5/2013Six Biopharma Leaders Made the 2013 Forbes China Best CEOs List

7/5/2013Latest Executive Moves

7/4/2013Guangdong Expands Its Essential Drug Supplement List

7/4/2013Updated - NDRC Initiates New Price Survey of Selected Pharmaceutical C...

7/4/2013What Happened to Outsourcing in Asia? (External)

7/4/2013Pharming, SIPI in Tech Transfer/Licensing Deal for Hereditary Angioede...

7/3/2013New Report: Chinese Companies Boost Investment into Biologic Drugs

7/3/2013IMF Licenses Rotavirus First-ever Oral Rotavirus Vaccine to China

7/3/2013Stakeholders Cheers TCM Legislation and Demands Separate Registration ...

7/3/2013Will NDRC Turn to Pharma Next for Its Anti-monopoly Investigation over...

7/2/2013Qinghai Introduces Provincial Level Essential Drug Supplement to 2012 ...

7/2/2013Renhe Pharma Acquires Dongke Pharma for CNY 360M

7/2/2013Shanghai RAAS Acquires Banghe Pharma

7/2/2013China Maintains Antidumping Duties on SMZ from India

7/2/2013Acebright to Acquire 10% Stake in Immunotherapeutics Developer NasVax

7/1/2013Upcoming Event: Pharma 2013: Sales & Marketing Excellence

7/1/2013Chinese Police Raids GSK Offices Amid Investigation for "Economic...

7/1/2013Shanghai Pharma Acquires 79% of Jiangsu Dong Ying Pharma for CNY 615M

Page:501/773 Total number of articles:23178: [First][<<] [499] [500] [501] [502] [503] [>>] [End]